DetaiBio is a CRO focusing on early antibody discovery, interaction protein discovery, protein and antibody development, with SingleB® Fast mAb Discovery platform, DeepLight® Function Pre Screening platform, BGE® HTP Expression platform and other advanced production technology platforms. Based on the above technical platforms and comprehensive IVD detection platform, DetaiBio launched chemiluminescence, immunochromatography, immunoturbidimetry, ELISA and other IVD platform reagent development services, covering the whole process from antibody development, pairing screening, platform verification, process optimization to recombinant large-scale production.
1
SingleB® Fast mAb Discovery
“1+1”double screening, which directly screen the specific memory B cells and plasma cells in PBMC, and it only takes 49 days to deliver 5-10 ELISA positive antibody sequences and expression plasmids.
2
DeepLight® Function Pre Screening
On-chip function pre screening technology directly selects strong positive plasma cells that can secrete functional antibodies.
3
BGE® HTP Antibody Expression
Independent proEM™ HTP vector and transfected directionally domesticated CHO/HEK293 cells, with 2 weeks speedy delivery.
DetaiBio has many independent IVD detection platforms, including ALP chemiluminescence, AE chemiluminescence, TRFIA, colloidal gold, latex turbidity, flow cytometry, ELISA, etc., which can provide professional reagent raw material screening, application performance verification, reagent performance optimization and OEM services. Currently, DetaiBio has reached cooperation with domestic mainstream chemiluminescence IVD enterprises on biomarkers containing tumor, hormones, thyroid function, myocardium and other markers.
Stage | Service | Timeline | Deliverables |
---|---|---|---|
Stage Ⅰ Animal Immunization |
| 2-4 weeks |
|
Stage Ⅱ “1+1”Double Screening |
| 1 day | |
Stage Ⅲ BGE® HTP Expression & Functional Test |
| 1-2 weeks | |
Stage Ⅳ Monoclonal Antibody Gene Sequencing |
| 1 week | |
Stage Ⅴ Monoclonal Antibody Pairing Screening (optional) |
| For enquiry | |
Stage Ⅵ Application Platform Validation (optional) |
| For enquiry | |
Stage Ⅶ Process Optimization (optional) |
| For enquiry | |
Stage Ⅷ Recombinant Antibody Expression & Purification (optional) |
| For enquiry |